IF by specialty › Infectious Diseases
Antimicrobial Agents and Chemotherapy — Impact Factor
The 2025 Impact Factor of Antimicrobial Agents and Chemotherapy is 4.2 (Q1 in Infectious Diseases; subscription or hybrid).
- Impact Factor
- 4.2 JCR 2025
- JCR category
- Infectious Diseases
- Quartile
- Q1 in Infectious Diseases
- Publisher
- American Society for Microbiology
- Open access
- subscription or hybrid
- IF source
- –
Position within the field
Ranked 19 of the 42 journals in Infectious Diseases on this site (top 50%).
Infectious Diseases journals with a similar Impact Factor
- International Journal of Infectious Diseases IF 4.6
- The Journal of Infectious Diseases IF 4.1
- Journal of Antimicrobial Chemotherapy IF 4.1
- Infectious Disease Clinics of North America IF 4.1
- Infection IF 3.9
- Open Forum Infectious Diseases IF 3.8
About this value
The Journal Impact Factor of Antimicrobial Agents and Chemotherapy (JCR 2025, released June 2026) is 4.2. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Infectious Diseases.